EPO Patents = 2

Forward Citations = 19

Loading Chart...

7 inventors (with patents filed for the assignee):

Jeannick Cizeau (7 out of 17 patents)

Glen MacDonald (6 out of 16 patents)

Francina C Chahal (5 out of 10 patents)

4. Nicholas Ronald Glover (2 out of 13 patents)

5. Joycelyn Entwistle (2 out of 9 patents)

6. Arjune Premsukh (1 out of 2 patents)

7. Denis Bosc (1 out of 2 patents)

8. Nicholas R Glover (0 patent)

7 patents: Sort by Forward Citations

1. 8389286 - Cancer-associated antigen (2013-03-05),

2. 8383117 - CD44E tumor specific antibody (2013-02-26),

3. 8318472 - Optimized nucleic acid sequences for the expression of VB4-845 (2012-11-27),

4. 8273550 - Antibodies against a cancer-associated epitope of variant HnRNPG and uses thereof (2012-09-25),

5. 8263744 - Binding proteins that bind to EpCAM linked to an effector molecule (2012-09-11),

6. 8084576 - Cancer associated glucose transporter 8 variant (2011-12-27),

7. 7956162 - Cancer-associated antigen (2011-06-07),

Viventia Biotechnologies Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. With a focus on antibody-drug conjugates and immuno-oncology treatments, Viventia aims to improve outcomes for cancer patients. Their cutting-edge research and development efforts have led to promising advancements in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

7 Patents

#98 in Mississauga

#2,027 in Canada

Mississauga, Canada

Viventia Biotechnologies Inc.